Martin Inzinger

Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: January 22, 2023

Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: January 22, 2023

Die Teledermatologische Beurteilung einer Psoriasis-Zielläsion und der vom Patienten selbst berechnete PASI sind suiffizient für das Psoriasis-Monitoring.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: July 21, 2021

Teledermatological assessment of one psoriasis target lesion and patient-reported-PASI are sufficient for psoriasis monitoring.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: April 24, 2021

Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.

Journal: The British journal of dermatology

Published: November 28, 2020

Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: October 30, 2015

Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.

Journal: Acta dermato-venereologica

Published: August 14, 2015

Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.

Journal: The British journal of dermatology

Published: February 24, 2015

Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agents.

Journal: The British journal of dermatology

Published: March 27, 2014

Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022.

Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022.

Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022.

Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022.

Die Teledermatologische Beurteilung einer Psoriasis-Zielläsion und der vom Patienten selbst berechnete PASI sind suiffizient für das Psoriasis-Monitoring.

Die Teledermatologische Beurteilung einer Psoriasis-Zielläsion und der vom Patienten selbst berechnete PASI sind suiffizient für das Psoriasis-Monitoring.

Teledermatological assessment of one psoriasis target lesion and patient-reported-PASI are sufficient for psoriasis monitoring.

Teledermatological assessment of one psoriasis target lesion and patient-reported-PASI are sufficient for psoriasis monitoring.

Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.

Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.

Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.

Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.

Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.

Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.

Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.

Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.

Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agents.

Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agents.

Peripheral streaks or leaf-like structures--that's the question

Peripheral streaks or leaf-like structures--that's the question

Hair repigmentation in melanoma.

Hair repigmentation in melanoma.

UV-induced alterations of the skin evaluated over time by reflectance confocal microscopy.

UV-induced alterations of the skin evaluated over time by reflectance confocal microscopy.